GlassScriptPhysician profile
Caleb D Thompson
NPI 1962606913
$14,959.55
in general payments reported to CMS, 2019-2025
19 companies · $5,176 in 2025
The $5,176 reported for 2025 was more than what 83% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,603 · 2020: $557 · 2021: $473 · 2022: $1,260 · 2023: $2,545 · 2024: $3,344 · 2025: $5,176.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,361 · Travel and Lodging: $4,423 · Long Term Medical Supply Or Device Loan: $282.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,360.72 |
| Travel and Lodging | $4,422.99 |
| Long Term Medical Supply Or Device Loan | $281.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,420.39 | 2019-2025 | Triclip, Mitraclip, Portico |
| Edwards Lifesciences Corporation | $3,937.14 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abiomed | $2,601.39 | 2019-2025 | Impella |
| Boston Scientific Corporation | $1,220.39 | 2019-2025 | Avvigo Guidance System, Watchman Access System |
| Medtronic, INC. | $941.91 | 2021-2025 | Corevalve Evolut R, Ffrangio, In.Pact Admiral |
| Medtronic Vascular, INC. | $556.14 | 2019-2020 | |
| Biosense Webster, INC. | $238.22 | 2024-2025 | Nuvision Ice Catheter |
| Shockwave Medical, INC | $220.85 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Philips North America LLC | $185.19 | 2021-2025 | Igt Devices Undivided |
| W. L. Gore & Associates, INC. | $140.92 | 2023 | Gore Cardioform Septal Occluder |
| Penumbra, INC. | $129.49 | 2023 | Indigo System |
| Acist Medical Systems, INC. | $100.00 | 2023 | |
| Silk Road Medical, INC. | $79.70 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Cardiva Medical, INC. | $46.55 | 2025 | Savvywire |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $38.35 | 2022-2023 | Lifevest |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $37.51 | 2019 | |
| Cvrx, INC. | $29.86 | 2023 | Barostim Neo System |
| Regeneron Healthcare Solutions, INC. | $18.33 | 2019 | |
| Janssen Pharmaceuticals, INC | $17.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caleb Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.